Oral Delivery of the Vancomycin Derivative FU002 by a Surface‐Modified Liposomal NanocarrierJulia Werner, Philipp Uhl, Tobias Hertlein et al.|Advanced Healthcare Materials|2024Cited by 28
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrierJulia Werner, Philipp Uhl, Tobias Hertlein et al.|Nanomedicine Nanotechnology Biology and Medicine|2023Cited by 11
Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and PharmacokineticsFlorian Umstätter, Philipp Uhl, Tobias Hertlein et al.|Pharmaceuticals|2022Cited by 10
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β‐Lactam AntibioticsJulia Werner, Philipp Uhl, Tobias Hertlein et al.|Advanced Science|2024Cited by 5
Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin ResistanceSari Rasheed, Philipp Uhl, Tobias Hertlein et al.|Advanced Therapeutics|2025Cited by 3